Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yukie Shirasaki"'
Publikováno v:
Japanese Journal of Cardiovascular Surgery. 48:185-188
Publikováno v:
World Journal of Cardiovascular Surgery. :97-107
Objectives: To investigate the influence of cold renal perfusion on renal function and clinical outcomes in cases where the renal ischemia time exceeded 30 min during pararenal and juxtarenal abdominal aortic aneurysm (P/JAAA) surgery. Methods and Re
Autor:
Kunihide Nakamura, Eisaku Nakamura, Yukie Shirasaki, Nobuhiko Ichiki, Koji Furukawa, Tomoka Hamahiro, Kazuhiro Higuchi, Hirohito Ishii, Daichi Sakurahara
Publikováno v:
Annals of Vascular Diseases
Spinal cord ischemia (SCI) is a devastating complication following thoracic endovascular aortic repair (TEVAR). A man with a ruptured thoracic aortic aneurysm (TAA) was transferred to our hospital. Emergency TEVAR, with left subclavian artery (LSA) c
Autor:
Kunihide Nakamura, Hirohito Ishi, Kouichiro Ochiai, Yukie Shirasaki, George Endo, Koji Furukawa, Eisaku Nakamura
Publikováno v:
Japanese Journal of Cardiovascular Surgery. 46:114-118
Publikováno v:
General thoracic and cardiovascular surgery. 68(6)
An 84-year-old man who underwent percutaneous coronary intervention for acute inferior myocardial infarction due to occlusion of the mid portion of the right coronary artery was transferred to our hospital because of post-infarction posterior ventric
Autor:
Kousuke Mori, Kunihide Nakamura, Yukie Shirasaki, Masanori Nishimura, Hirohito Ishii, Eisaku Nakamura, Jogi Endo
Publikováno v:
Japanese Journal of Cardiovascular Surgery. 45:80-83
Autor:
Kunihide Nakamura, Kousuke Mori, Eisaku Nakamura, Masanori Nishimura, Yukie Shirasaki, Joji Endo, Hirohito Ishii
Publikováno v:
Japanese Journal of Cardiovascular Surgery. 45:229-232
Autor:
Kunihide Nakamura, Masaki Tomita, Eiichi Chosa, Yukie Shirasaki, Makoto Ikenoue, Takanori Ayabe
Publikováno v:
Journal of Cancer Therapy. :281-296
Background: This retrospective study was to evaluate the efficacy and toxicity of gemcitabine plus carboplatin (GC regimen) and paclitaxel plus carboplatin (PC regimen) combination chemotherapy in elderly patients with non-small cell lung cancer. Met